EU approves two Edwards patient monitoring platforms

Kaitlyn Dmyterko | November 08, 2010 | Health Exec | Precision Medicine

The European Union has granted Edwards Lifesciences a CE mark for its VolumeView sensor-catheter set, a device that monitors a patient’s hemodynamics, and its EV1000 clinical monitoring platform that displays patient's physiological status.

The EV1000 platform integrates sensors and catheters into a single system and is equipped with a touch-screen monitor that displays color-coded clinical targets and alerts. Edwards’ FloTrac sensor, PediaSat and PreSep oximetry cathers, the TruWave pressure transducer, along with the VolumeView, are compatible with the EV1000 platform.

The VolumeView system, when used in combination with the EV1000 platform, can output volumetric parameters including fluid volume in the lungs and global end-diastolic volume, Irvine, Calif.-based Edwards said.

Kaitlyn Dmyterko

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

EU approves two Edwards patient monitoring platforms

Related Content

Around the web